Showing results (61-70 of 94) with videos related to

Sort By:
Pageof 10
International Journal of Cancer|February 10, 2015
Intact and cleaved plasma soluble urokinase receptor in patients with metastatic colorectal cancer treated with oxaliplatin with or without cetuximabLine S Tarpgaard, Ib J Christensen, Gunilla Høyer-Hansen, et al.
Journal of Neuroendocrinology|June 22, 2022
Volumetric parameters from [18 F]FDG PET/CT predicts survival in patients with high-grade gastroenteropancreatic neuroendocrine neoplasmsHenning Langen Stokmo, Mahmoud Aly, Inger Marie Bowitz Lothe, et al.
British Journal of Cancer|April 25, 2024
First-line oxaliplatin-based chemotherapy and nivolumab for metastatic microsatellite-stable colorectal cancer-the randomised METIMMOX trialAnne Hansen Ree, Jūratė Šaltytė Benth, Hanne M Hamre, et al.
British Journal of Cancer|June 22, 2024
Treatment outcome according to genetic tumour alterations and clinical characteristics in digestive high-grade neuroendocrine neoplasmsHege Elvebakken, Andreas Venizelos, Aurel Perren, et al.
Virchows Archiv : an International Journal of Pathology|November 15, 2017
Treatment-related survival associations of claudin-2 expression in fibroblasts of colorectal cancerArtur Mezheyeuski, Carina Strell, Ina Hrynchyk, et al.
Endocrine-Related Cancer|October 14, 2021
The molecular characteristics of high-grade gastroenteropancreatic neuroendocrine neoplasmsAndreas Venizelos, Hege Elvebakken, Aurel Perren, et al.
Acta Oncologica (Stockholm, Sweden)|May 17, 2023
Nordic 2023 guidelines for the diagnosis and treatment of lung neuroendocrine neoplasmsGitte Dam, Henning Grønbæk, Anna Sundlöv, et al.
Pageof 10